$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

$cpsh Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000143774923030150 Filed on November 03, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$6.747M	$7.418M
YoY Change	-0.01%	4.91%
Cost Of Revenue	$5.599M	$5.222M
YoY Change	15.08%	-0.39%
Gross Profit	$1.149M	$2.196M
YoY Change	-39.01%	20.1%
Gross Profit Margin	17.02%	29.61%
Selling, General & Admin	$1.005M	$1.465M
YoY Change	-14.44%	26.42%
% of Gross Profit	87.49%	66.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$125.8K	$128.4K
YoY Change	19.99%
% of Gross Profit	10.95%	5.84%
Operating Expenses	$1.005M	$1.465M
YoY Change	-14.44%	26.42%
Operating Profit	$143.6K	$730.9K
YoY Change	-79.73%	9.18%
Interest Expense	$49.43K	-$1.360K
YoY Change	-2715.34%	-185.53%
% of Operating Profit	34.41%	-0.19%
Other Income/Expense, Net	$31.39K	$81.02K
YoY Change	-95.14%
Pretax Income	$224.5K	$810.6K
YoY Change	-83.4%	20.79%
Income Tax	$84.95K	$210.1K
% Of Pretax Income	37.85%	25.92%
Net Earnings	$139.5K	$600.5K
YoY Change	-85.88%	31.95%
Net Earnings / Revenue	2.07%	8.1%
Basic Earnings Per Share		$0.04
Diluted Earnings Per Share	$0.01	$0.04
COMMON SHARES
Basic Shares Outstanding	14.52M	14.49M
Diluted Shares Outstanding		14.62M

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.814M	$8.681M
YoY Change	57.43%	71.02%
Cash & Equivalents	$8.814M	$8.681M
Short-Term Investments
Other Short-Term Assets	$276.4K	$288.3K
YoY Change	12.03%	-8.03%
Inventory	$4.582M	$4.814M
Prepaid Expenses
Receivables	$4.389M	$5.075M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$18.14M	$18.93M
YoY Change	9.64%	29.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.556M	$1.508M
YoY Change	10.46%	6.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.570M	$1.664M
YoY Change	-25.89%	-32.98%
Total Long-Term Assets	$3.458M	$3.572M
YoY Change	-14.07%	-19.26%
TOTAL ASSETS
Total Short-Term Assets	$18.14M	$18.93M
Total Long-Term Assets	$3.458M	$3.572M
Total Assets	$21.60M	$22.50M
YoY Change	5.0%	18.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.535M	$2.360M
YoY Change	23.97%	45.54%
Accrued Expenses	$1.075M	$861.5K
YoY Change	24.22%	7.0%
Deferred Revenue	$251.8K	$1.828M
YoY Change	-85.25%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$46.80K	$56.68K
YoY Change	8.48%	19.78%
Total Short-Term Liabilities	$4.069M	$5.264M
YoY Change	-15.54%	24.55%
LONG-TERM LIABILITIES
Long-Term Debt	$8.090K	$20.44K
YoY Change	-87.73%	-73.5%
Other Long-Term Liabilities	$203.3K	$273.3K
YoY Change	-40.21%	-26.34%
Total Long-Term Liabilities	$211.4K	$293.7K
YoY Change	-47.93%	-34.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.069M	$5.264M
Total Long-Term Liabilities	$211.4K	$293.7K
Total Liabilities	$4.280M	$5.558M
YoY Change	-18.06%	18.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.75M	-$23.07M
YoY Change	-6.72%
Common Stock	$146.0K	$145.5K
YoY Change	1.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$250.1K
YoY Change	1099.76%
Treasury Stock Shares
Shareholders Equity	$17.32M	$14.34M
YoY Change
Total Liabilities & Shareholders Equity	$21.60M	$22.50M
YoY Change	5.0%	18.34%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$139.5K	$600.5K
YoY Change	-85.88%	31.95%
Depreciation, Depletion And Amortization	$125.8K	$128.4K
YoY Change	19.99%
Cash From Operating Activities	$196.9K	$1.555M
YoY Change	-70.23%
INVESTING ACTIVITIES
Capital Expenditures	$150.9K	$257.0K
YoY Change	-249.93%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	-$150.9K	-$257.0K
YoY Change	49.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.23K	13.38K
YoY Change	-70.83%
NET CHANGE
Cash From Operating Activities	196.9K	1.555M
Cash From Investing Activities	-150.9K	-257.0K
Cash From Financing Activities	-11.23K	13.38K
Net Change In Cash	34.77K	1.311M
YoY Change	-93.34%
FREE CASH FLOW
Cash From Operating Activities	$196.9K	$1.555M
Capital Expenditures	$150.9K	$257.0K
Free Cash Flow	$46.00K	$1.298M
YoY Change	-93.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2832509
	dei	Entity Address Address Line1 EntityAddressAddressLine1	111 South Worcester Street
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14601487
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14460486
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14519215
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14450470
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	82272
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	10016
CY2023Q3	us-gaap	Revenues Revenues	6285041	usd
CY2022Q4	us-gaap	Revenues Revenues	6748117	usd
	us-gaap	Revenues Revenues	20803447	usd
	us-gaap	Revenues Revenues	20471574	usd
CY2022Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-16088
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address City Or Town EntityAddressCityOrTown	Norton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02766-2102
	dei	City Area Code CityAreaCode	508
	dei	Local Phone Number LocalPhoneNumber	222-0614
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	CPSH
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14519215
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8778856	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8266753	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5006451	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3777975	usd
CY2023Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	17043	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	685668	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	4827957	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4875901	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	337476	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	211242	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	18967783	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	17817539	usd
CY2023Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	11195993	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10770427	usd
CY2023Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	952883	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	952883	usd
CY2023Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	985649	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	985649	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13134525	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12708959	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11810209	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11446901	usd
CY2023Q3	cpsh	Construction In Progress Net ConstructionInProgressNet	206693	usd
CY2022Q4	cpsh	Construction In Progress Net ConstructionInProgressNet	64910	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1531009	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1326968	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	367000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	466000	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1645467	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2069436	usd
CY2023Q3	us-gaap	Assets Assets	22511259	usd
CY2022Q4	us-gaap	Assets Assets	21679943	usd
CY2023Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	57457	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	43711	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2151127	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1836865	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1067293	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	820856	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1675086	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2521128	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	159000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	157000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5109963	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5379560	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	8655	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	54847	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	31277	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	231020	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	208000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	309000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	5357895	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5974427	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	146015	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	144605	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40151794	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39726851	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22894307	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24125092	usd
CY2023Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	250138	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	40848	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	17153364	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15705516	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22511259	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21679943	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6285041	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6748117	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20803447	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20471574	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5049177	usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4864876	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15126621	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14796206	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1235864	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	1883241	usd
	us-gaap	Gross Profit GrossProfit	5676826	usd
	us-gaap	Gross Profit GrossProfit	5675368	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1105227	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1174581	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4121099	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3750131	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	130637	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	708660	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1555727	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1925237	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	78181	usd
CY2022Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1892	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	176325	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-6245	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1228	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	645594	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4130	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	649628	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	207590	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1352362	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1727922	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2568620	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36509	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	364497	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	497137	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	706211	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	171081	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	987865	usd
	us-gaap	Net Income Loss NetIncomeLoss	1230785	usd
	us-gaap	Net Income Loss NetIncomeLoss	1862409	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14517364
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14434468
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14487873
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14417995
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14636241
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14686476
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14632591
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14683632
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	16946592	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27941	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7750	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	171081	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	17153364	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15705516	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	175698	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	41365	usd
	us-gaap	Net Income Loss NetIncomeLoss	1230785	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	17153364	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	14341676	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	43422	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	23135	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	987865	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15349828	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13166311	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	207277	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	40893	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	154724	usd
	us-gaap	Net Income Loss NetIncomeLoss	1862409	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15349828	usd
	us-gaap	Net Income Loss NetIncomeLoss	1230785	usd
	us-gaap	Net Income Loss NetIncomeLoss	1862409	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	363308	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	316469	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	175698	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	207277	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-423969	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-705755	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1228476	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	965717	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-668625	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-47944	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	956948	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	126234	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	20807	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	314262	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-55394	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1045785	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	246437	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-220891	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1070533	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	872153	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	567349	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	392286	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-567349	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-392286	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	41365	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	154724	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-40893	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	32446	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	45507	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8918	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	68324	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	512103	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	548191	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8266753	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5050312	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8778856	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5598503	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	109456	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	456	usd
	us-gaap	Interest Paid Net InterestPaidNet	4130	usd
	us-gaap	Interest Paid Net InterestPaidNet	6243	usd
	us-gaap	Stock Issued1 StockIssued1	209290	usd
	us-gaap	Stock Issued1 StockIssued1	18334	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	171081	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	987865	usd
	us-gaap	Net Income Loss NetIncomeLoss	1230785	usd
	us-gaap	Net Income Loss NetIncomeLoss	1862409	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14517364
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14434468
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14487873
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14417995
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	171081	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	987865	usd
	us-gaap	Net Income Loss NetIncomeLoss	1230785	usd
	us-gaap	Net Income Loss NetIncomeLoss	1862409	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14517364
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14434468
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14487873
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14417995
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	118877
CY2022Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	252008
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	144718
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	265637
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14636241
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14686476
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14632591
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14683632
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2023Q3	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	38000
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	41000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	165000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	165000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	27000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	398000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	31000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	367000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	159000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	208000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	367000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P29Y
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.066	pure
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	55000
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.65
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	27400
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0
CY2022Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	10000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0
CY2023Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	138200
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	901900
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.67
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M12D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	497000
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.43
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y9M18D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1500000
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	834300
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	28000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	176000	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	43000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	207000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	2781188	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2645442	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	1512835	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1863512	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	729359	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	525872	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	5023382	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	5034826	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	195425	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	158925	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	4827957	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4875901	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	69189	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	35398	usd
CY2023Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	795952	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	760305	usd
CY2023Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	202152	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	25153	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1067293	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	820856	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	11265	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	46757	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	8090	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	66112	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	4130	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	73	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	424	usd
CY2023Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	18	usd
CY2023Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	19	usd

Files In Submission

Name	View Source	Status
0001437749-23-030150-index-headers.html	Edgar Link	pending
0001437749-23-030150-index.html	Edgar Link	pending
0001437749-23-030150.txt	Edgar Link	pending
0001437749-23-030150-xbrl.zip	Edgar Link	pending
cpsh-20230930.xsd	Edgar Link	pending
cpsh20230929_10q.htm	Edgar Link	pending
ex_586316.htm	Edgar Link	pending
ex_586317.htm	Edgar Link	pending
cpsh-20230930_def.xml	Edgar Link	unprocessable
cpsh-20230930_cal.xml	Edgar Link	unprocessable
cpsh-20230930_pre.xml	Edgar Link	unprocessable
cpsh-20230930_lab.xml	Edgar Link	unprocessable
cpsh20230929_10q_htm.xml	Edgar Link	completed
ex_586318.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

2023 Q4 Form 10-Q Financial Statement

#000143774923030150 Filed on November 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSH CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

2023 Q4 Form 10-Q Financial Statement

#000143774923030150 Filed on November 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh